Tim Raine
Impact in
- Genetics top 0.1%
- Inflammatory Bowel Disease
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
- Genetics 101
- Inflammatory Bowel Disease 96
- Diabetes and associated disorders 5
- Rheumatology 11
- Spondyloarthritis Studies and Treatments 9
- Co-authors
- Marcus Harbord (2 shared papers)Rami Eliakim (2 shared papers)Herbert Tilg (5 shared papers)Alexander Rupert Moschen (2 shared papers)Anne Cooke (6 shared papers)Fernando Magro (2 shared papers)Jimmy K. Limdi (3 shared papers)Ailsa L Hart (2 shared papers)
- Journals
- Journal of Crohn s and Colitis (36 papers)The Lancet. Gastroenterology & hepatology (13 papers)Gut (12 papers)Lara D. Veeken (6 papers)Inflammatory Bowel Diseases (6 papers)
- Partner nations
- United KingdomUnited StatesBelgium
In The Last Decade
Tim Raine
155 papers receiving 14.5k citations
Tim Raine's Hit Papers
Peers
Comparison fields: 5 of 145
- Genetics 9.7k
- Infectious Diseases 951
- Immunology 905
- General Dentistry 18
- Rheumatology 483
Countries citing papers authored by Tim Raine
This map shows the geographic impact of Tim Raine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Raine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Raine more than expected).
Fields of papers citing papers by Tim Raine
This network shows the impact of papers produced by Tim Raine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Raine. The network helps show where Tim Raine may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim Raine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 174 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults Hit paper breakdown → | 2019 | 1804 |
| 2 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders Hit paper breakdown → | 2017 | 1531 |
| 3 | ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment Hit paper breakdown → | 2019 | 1058 |
| 4 | Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management Hit paper breakdown → | 2017 | 981 |
| 5 | ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment Hit paper breakdown → | 2019 | 915 |
| 6 | ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment Hit paper breakdown → | 2021 | 750 |
| 7 | The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease Hit paper breakdown → | 2015 | 630 |
| 8 | Paneth cells as a site of origin for intestinal inflammation Hit paper breakdown → | 2013 | 617 |
| 9 | ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment Hit paper breakdown → | 2021 | 443 |
| 10 | 2020 | 395 | |
| 11 | IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting Hit paper breakdown → | 2018 | 386 |
| 12 | 2021 | 224 | |
| 13 | 2007 | 222 | |
| 14 | ECCO Guidelines on Inflammatory Bowel Disease and Malignancies Hit paper breakdown → | 2022 | 214 |
| 15 | British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic Hit paper breakdown → | 2020 | 213 |
| 16 | 2016 | 212 | |
| 17 | 2006 | 196 | |
| 18 | ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment Hit paper breakdown → | 2024 | 193 |
| 19 | A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial Hit paper breakdown → | 2024 | 182 |
| 20 | 2018 | 175 |
About Tim Raine
Tim Raine is a scholar working on Genetics, Rheumatology, Oncology, Immunology and Surgery, having authored 174 papers that have together received 14.8k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (96 papers), Medical research and treatments (9 papers), Spondyloarthritis Studies and Treatments (9 papers), SARS-CoV-2 and COVID-19 Research (7 papers), Colorectal Cancer Screening and Detection (5 papers), Diabetes and associated disorders (5 papers), Pain Mechanisms and Treatments (5 papers) and Artificial Intelligence in Healthcare and Education (4 papers). The work is most often cited by research in Genetics (9.7k citations), Infectious Diseases (951 citations), Immunology (905 citations), General Dentistry (18 citations) and Rheumatology (483 citations). Tim Raine has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Marcus Harbord, Rami Eliakim, Herbert Tilg, Alexander Rupert Moschen, Anne Cooke, Fernando Magro, Jimmy K. Limdi, Ailsa L Hart, Johan M. Burisch and Paolo Gionchetti. Their work appears in journals such as Journal of Crohn s and Colitis, The Lancet. Gastroenterology & hepatology, Gut, Lara D. Veeken and Inflammatory Bowel Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.